دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Treating obesity and diabetes: drugs alone are not enough
doi : 10.1016/S0140-6736(24)00003-5
Volume 403, Issue 10421, 6–12 January 2024, Page 1
Improving survival from metastatic, recurrent, or persistent cervical cancer
*Linda R Mileshkin, Sathya Manoharan
doi : 10.1016/S0140-6736(23)02690-9
Volume 403, Issue 10421, 6–12 January 2024, Pages 2-4
Scaling up multifaceted interventions in maternity care: will they work?
Leandro De Oliveira, Tahir Bockarie, *Lucy C Chappell
doi : 10.1016/S0140-6736(23)02503-5
Volume 403, Issue 10421, 6–12 January 2024, Pages 4-6
Universal paediatric screening for familial hypercholesterolaemia
*Mary P McGowan, Marina Cuchel
doi : 10.1016/S0140-6736(23)02182-7
Volume 403, Issue 10421, 6–12 January 2024, Pages 6-8
Tackling health emergencies in complex settings: the role of national public health institutes in the Eastern Mediterranean region
Wasiq Khan, Aamer Ikram, Sara Hersey, John Grundy, Sadaf Lynes, Mamunur Malik, Awad Mataria, Richard Brennan
doi : 10.1016/S0140-6736(23)02696-X
Volume 403, Issue 10421, 6–12 January 2024, Pages 8-10
Health-worker education for disability inclusion in health
Luthfi Azizatunnisa, Sara Rotenberg, *Tom Shakespeare, Satendra Singh, Tracey Smythe
doi : 10.1016/S0140-6736(23)02707-1
Volume 403, Issue 10421, 6–12 January 2024, Pages 11-13
Humanitarian appeals for 2024 face severe funding losses
John Zarocostas
doi : 10.1016/S0140-6736(24)00001-1
Volume 403, Issue 10421, 6–12 January 2024, Pages 14-15
Steady but variable progress towards global HIV targets
Tony Kirby
doi : 10.1016/S0140-6736(24)00002-3
Volume 403, Issue 10421, 6–12 January 2024, Pages 16-17
Bruce Richman: building the U=U movement for HIV prevention
Tony Kirby
doi : 10.1016/S0140-6736(23)02699-5
Volume 403, Issue 10421, 6–12 January 2024, Page 18
In the land of pain
Marco De Ambrogi
doi : 10.1016/S0140-6736(23)02840-4
Volume 403, Issue 10421, 6–12 January 2024, Page 19
Sustainable engagement
Jennifer Furin
doi : 10.1016/S0140-6736(23)02841-6
Volume 403, Issue 10421, 6–12 January 2024, Pages 20-21
William Philip Trehearne James
Geoff Watts
doi : 10.1016/S0140-6736(23)02842-8
Volume 403, Issue 10421, 6–12 January 2024, Page 22
No evidence of inflated mortality reporting from the Gaza Ministry of Health
Benjamin Q Huynh, Elizabeth T Chin, Paul B Spiegel
doi : 10.1016/S0140-6736(23)02713-7
Volume 403, Issue 10421, 6–12 January 2024, Pages 23-24
End humanitarian catastrophe in conflict settings
Caroline S E Homer, on behalf of the Strategic and Technical Advisory Group of Experts on maternal, newborn, child, and adolescent health and nutrition
doi : 10.1016/S0140-6736(23)02695-8
Volume 403, Issue 10421, 6–12 January 2024, Pages 24-25
The health dimensions of violence in Palestine: a call to prevent genocide
Alix Faddoul, Geordan Shannon, Khudejha Asghar, Yamina Boukari, James Smith, Amy Neilson
doi : 10.1016/S0140-6736(23)02751-4
Volume 403, Issue 10421, 6–12 January 2024, Pages 25-26
There is no way to leave Gaza
Salam
doi : 10.1016/S0140-6736(23)02676-4
Volume 403, Issue 10421, 6–12 January 2024, Pages 26-27
The conflict in Gaza—are data ever enough?
Amitava Banerjee
doi : 10.1016/S0140-6736(23)02637-5
Volume 403, Issue 10421, 6–12 January 2024, Page 27
The REVAMP trial: key questions remain
Bingwen Eugene Fan
doi : 10.1016/S0140-6736(23)01916-5
Volume 403, Issue 10421, 6–12 January 2024, Pages 27-28
The REVAMP trial: key questions remain
Deku Liang, Yonghong Lin, *Li He
doi : 10.1016/S0140-6736(23)01917-7
Volume 403, Issue 10421, 6–12 January 2024, Page 28
The REVAMP trial: key questions remain
Alizée Froeliger, Hugo Madar, Hanane Bouchghoul, Catherine Deneux-Tharaux, *Loïc Sentilhes
doi : 10.1016/S0140-6736(23)01918-9
Volume 403, Issue 10421, 6–12 January 2024, Page 28
The REVAMP trial: key questions remain
Qin-Yu Cai, Bei-Ning Deng, *Tai-Hang Liu
doi : 10.1016/S0140-6736(23)01919-0
Volume 403, Issue 10421, 6–12 January 2024, Pages 28-29
The REVAMP trial: key questions remain
Qin-Yu Cai, Bei-Ning Deng, *Tai-Hang Liu
doi : 10.1016/S0140-6736(23)01920-7
Volume 403, Issue 10421, 6–12 January 2024, Page 29
The REVAMP trial: key questions remain – Authors' reply
Sant-Rayn Pasricha, Ernest Moya, Ricardo Ataide, Glory Mzembe, Rebecca Harding, Kamija Phiri
doi : 10.1016/S0140-6736(23)01915-3
Volume 403, Issue 10421, 6–12 January 2024, Pages 29-30
Department of Error
doi : 10.1016/S0140-6736(23)02762-9
Volume 403, Issue 10421, 6–12 January 2024, Page 30
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial
Ana Oaknin, Laurence Gladieff, Jer?nimo Mart?nez-Garc?a, Guillermo Villacampa, Munetaka Takekuma, Ugo De Giorgi, Kristina Lindemann, Linn Woelber, Nicoletta Colombo, Linda Duska, Alexandra Leary, Ana Godoy-Ortiz, Shin Nishio, Antoine Angelergues, Maria Jes?s Rubio, Lorena Fari?as-Madrid, Satoshi Yamaguchi, Domenica Lorusso, Isabelle Ray-Coquard, Luis Manso, Florence Joly, Jes?s Alarc?n, Philippe Follana, Ignacio Romero, Coriolan Lebreton, J Alejandro Pérez-Fidalgo, Mayu Yunokawa, Hanna Dahlstrand, Véronique D’Hondt, Leslie M Randall for the ENGOT-Cx10–GEICO 68-C–JGOG1084–GOG-3030 Investigators
doi : 10.1016/S0140-6736(23)02405-4
Volume 403, Issue 10421, 6–12 January 2024, Pages 31-43
Perinatal morbidity among women with a previous caesarean delivery (PRISMA trial): a cluster-randomised trial
Nils Chaillet, Benoît Mâsse, William A Grobman, Allison Shorten, Robert Gauthier, Patrick Rozenberg, Marylène Dugas, Jean-Charles Pasquier, François Audibert, Haim A Abenhaim, Suzanne Demers, Bruno Piedboeuf, William D Fraser, Robert Gagnon, Guy-Paul Gagné, Diane Francoeur, Isabelle Girard, Louise Duperron, Marie-Josée Bédard, Mira Johri, Eric Dubé, Simon Blouin, Thierry Ducruet, Mario Girard, Emmanuel Bujold, for the PRISMA Trial research group
doi : 10.1016/S0140-6736(23)01855-X
Volume 403, Issue 10421, 6–12 January 2024, Pages 44-54
Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study
European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration*
doi : 10.1016/S0140-6736(23)01842-1
Volume 403, Issue 10421, 6–12 January 2024, Pages 55-66
Ultraviolet radiation manicure-related keratinocyte malignancies in a renal transplant recipient
Nicola Kearney, Nicholas Stefanovic, Muireann Roche
doi : 10.1016/S0140-6736(23)02524-2
Volume 403, Issue 10421, 6–12 January 2024, Page e1
Pathways to a healthy net-zero future: report of the Lancet Pathfinder Commission
Sarah Whitmee, Rosemary Green, Kristine Belesova, Syreen Hassan, Soledad Cuevas, Peninah Murage, Roberto Picetti, Romain Clercq-Roques, Kris Murray, Jane Falconer, Blanca Anton, Tamzin Reynolds, Hugh Sharma Waddington, Robert C Hughes, Joseph Spadaro, Aimée Aguilar Jaber, Yamina Saheb, Diarmid Campbell-Lendrum, Maria Cortés-Puch, Kristie Ebi, Rachel Huxley, Mariana Mazzucato, Tolu Oni, Nicole de Paula, Gong Peng, Aromar Revi, Johan Rockstr?m, Leena Srivastava, Lorraine Whitmarsh, Robert Zougmoré, Joy Phumaphi, Helen Clark, Andy Haines
doi : 10.1016/S0140-6736(23)02466-2
Volume 403, Issue 10421, 6–12 January 2024, Pages 67-110
Success from the South: the rotavirus vaccine story and its lessons
Gagandeep Kang
doi : 10.1016/S0140-6736(23)02520-5
Volume 403, Issue 10421, 6–12 January 2024, Pages 111-116
